from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0466/-

LFCtreatmentdescriptionclass of inhibitor

1.106

Amikacinug/mL Amikacintranslation

3.078

Cap5-10ug/mL Capreomycintranslation

2.886

Rox10-50 ug/mL Roxithromycintranslation

1.024

SM2-5 ug/mL Streptomycintranslation

2.115

Tet5-10 ug/mL Tetracyclinetranslation

0.148

Rif0.2-5ug/mL Rifampicintranscription

0.199

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.342

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.412

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.786

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.682

Clofazimine10-13 ug/mL Clofaziminerespiration

0.075

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.890

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.268

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.485

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.012

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.137

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.240

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.030

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.790

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.005

KCN5-20 ug/mL Potassium cyaniderespiration

-0.311

NaN30.2-2 mM Sodium aziderespiration

0.600

Nigericin50 uM Nigericinrespiration

-0.685

TRC10-150 ug/mL Triclosanrespiration

-1.598

TRZ10-25 ug/mL Thioridazinerespiration

-0.159

Valinomycin0.5-10 uM Valinomycinrespiration

0.327

ZnSO42 mM ZnSO4respiration

0.551

menadione6-10 ug/mL Menadionerespiration

-0.057

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.504

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.339

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.022

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.186

NRP_1Non-replicating persistence stage 1dosRassociated

0.069

Amp0.2mg/mL AmpicillincellWall

-0.056

Cephalexin20-100 ug/mL CephalexincellWall

0.910

Cerulenin0.32-5 ug/mL CerulenincellWall

0.421

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.105

EMB10-20 ug/mL EthambutolcellWall

-0.049

Eta12-40 ug/mL EthionamidecellWall

-0.033

INH0.2-0.4 ug/mL IsoniazidcellWall

0.196

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.082

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.457

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.054

BZA0.12 mg/mL BenzamidearomaticAmides

0.278

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.013

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.197

H2O24 mM hydrogen peroxideDNAdamaging

0.186

Levo10 ug/mL LevofloxacinDNAdamaging

0.927

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.480

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.102

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.561

UVUV-irradiationDNAdamaging

-0.703

ARP41-4 ug/mL Antitubercular compound ARP4?

0.385

Antimycin12.5-50 ug/mL Antimycin A?

0.778

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.504

PA_110-50 ug/mL Antitubercular compound PA-1?

0.456

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.667

PA8240.2-2 ug/mL PA-824?

-0.823

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.323

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.138

Verapamil50 uM Verapamil?

-0.316

mercaptoethanol2 mM 2-Mercaptoethanol?

0.421

methoxatin10-20 ug/mL Methoxatin?